Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide maps of chromatin state in 142 cancer cell lines [cell line]

ABSTRACT: Epigenetic aberrations are a hallmark of cancer; however, we have limited information on chromatin aberrations present in cancer cells. Here we provide genome-wide maps for histone modification binding for 6 reference histone markers in 145 cancer cell lines belonging to 9 cancer types generating 680 chromatin maps. NMF clustering for H3K27ac-defined enhancers classified cancer cells into 5 distinct subtypes. These subtypes were either correlated with the developmental trajectory of original tissue or cell phenotype such as mesenchymal features. We identify a cluster consisting of different tumor types but with a unique enhancer profile and its dependency on key oncogenes. Detailed characterization of bivalent state switches between cancer cells and their normal counterparts identified epithelial-to-mesenchymal driver transcription factors to be activated via this mechanism in breast, GBM and melanomas. Finally, we identify cancer-specific lengthening of H3K4me3 domains on oncogenes and their shortening on specific tumor-suppressors, respectively. Overall, our study provides epigenome reference maps for widely-used cancer cell lines which will be useful for discovery of important principles about chromatin mediated cancer gene regulation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE142751 | GEO | 2026/07/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq access dataset for epigenomics landscape of colorectal cancer

Project description:Enhancer aberrations are beginning to emerge as a key feature of colorectal cancers, however, we have limited understanding of epigenomic patterns that distinguish tumors and underlying heterogeneity between tumors. Here, using epigenomic profiling of colorectal tumors, adenomas and normal colon tissues, we identify unique pattern of regulatory elements in colorectal cancer, which could reliably distinguish tumors from normal colon specimens. We define shared and unique enhancer elements during colorectal cancer progression using normal adjacent colon, adenomas and adenocarcinomas. We validate the functional nature of tumor-specific enhancers for important oncogenes such as ASCL2 and Fzd10. NMF clustering identified 4 epigenetic (EPIC) subtypes in colorectal cancer, which mimics consensus molecular subtypes (CMS)1, with an advantage of introducing a novel epigenetically-identifiable subtype with poor prognosis and survival. Based on this correlation, we defined and validated a combination therapeutic strategy of enhancer-blocking BETi with pathway specific inhibitor for 3 CMS subtypes. In conclusion, by comprehensive characterization of chromatin state patterns in colorectal tumors, we define epigenomic patterns during tumor evolution, heterogeneity of enhancers among patients and a combination therapy strategy for CMS-subgroups.

2021-05-22 | GSE136630 | GEO

Hi-ChIP dataset for epigenomics landscape of colorectal cancer

2021-05-22 | GSE136629 | GEO

Epigenetic Landscapes in Breast Cancer Cells

Project description:Chromatin architecture is essential to transcriptional regulation. Cancer cells undergo critical chromatin remodeling processes that interact with the activation or silencing of oncogenes or tumor suppressor genes. These processes, together with other alterations of the functional status of chromatins, are characterized by epigenetic marks such as covalent histone modifications, DNA methylations and etc. The epigenetic landscapes defined by these marks are key to understand their regulatory mechanisms as well as the contributions to cancer onset and progression. In this study, we focus on defining the epigenetics landscapes across different breast cancer subtypes. Here we present a collection of 11 key histone modifications across 13 distinct breast cancer cell lines, representing 5 major breast cancer subtypes, including two ER positive subtypes: Lumina-A and Lumina-B, HER2 positive subtype and triple-negative subtypes TNBC-Basal and TNBC-ClaudinLow, as well as normal-like immortal breast cells. Using combinatorial patterns of multiple histone modifications, we defined the whole genome chromatin state maps and identified specific signatures in breast cancer subtypes.

2017-12-15 | GSE85158 | GEO

3D chromatin hubs as regulatory units of identity and survival in acute T-cell leukemia [HiChIP]

Project description:Cancer progression is associated with genetic and epigenetic aberrations that affect chromatin 3D organization in the nucleus. Changes in loop extrusion or phase separation alter the relationships between enhancer and promoter elements, defining novel gene expression programs that are selected to promote growth and survival. Here, we provide an integrative approach based on chromatin conformation, accessibility and transcription, further validated by CRISPR interference screenings in order to identify chromatin topologies relevant to different subtypes of T-cell leukemia, namely T-ALL and ETP-ALL. By focusing on highly interconnected elements, we characterized 3D hubs as headquarters of leukemia progression and identity, demonstrating that oncogenes and disease markers are regulated by multiple cis-regulatory regions.

2024-11-04 | GSE280796 | GEO

3D chromatin hubs as regulatory units of identity and survival in acute T-cell leukemia [etp82a_RNA-seq]

2024-11-04 | GSE280798 | GEO

3D chromatin hubs as regulatory units of identity and survival in acute T-cell leukemia [scATAC-Seq]

2024-11-04 | GSE280728 | GEO

3D chromatin hubs as regulatory units of identity and survival in acute T-cell leukemia [RNA-seq]

2023-09-25 | GSE243914 | GEO

3D chromatin hubs as regulatory units of identity and survival in acute T-cell leukemia [hiChIP]

2023-09-25 | GSE243913 | GEO

Twist1 Overexpression Models an Aggressive Subtype of Pancreatic Ductal Adenocarcinoma in vivo

Project description:Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with very poor survival outcomes. Genomic analyses have identified distinct molecular subtypes in human PDAC with quasimesenchymal/squamous/basal-like (QSB) having the worse prognosis. However, no in vivo models exist for QSB subtypes. The epithelial-mesenchymal transition (EMT) transcription factor TWIST1 is upregulated in QSB PDAC. We hypothesized that the TWIST1-dependent plasticity program is a key regulator of QSB PDAC subtype development. Non-negative matrix factorization (NMF) of human PDAC subtypes identified 3 NMF clusters. NMF1 was dominated by QSB subtypes, had the worst overall survival, and exhibited high TWIST1 expression. We generated a novel tetracycline-inducible autochthonous pancreas specific KrasG12D-Twist1 genetically engineered tumor mouse model (Pdx1 promoter-Cre (P); LSL-KrasG12D (R); LSL-rtTA-IRES-GFP (G); Twist1-tetO-Luc (T)). PGRT mice showed accelerated pancreatic tumor development and decreased overall median survival compared to PGR (KrasG12D alone) mice (4.6 months vs 9.7 months, p< 0.0001). Histological analyses showed that PGRT pancreatic tumors spanned a spectrum of PDAC to QSB PDAC subtype, exhibited an EMT profile and squamous histology. Twist1 induction resulted in increased metastases (9.52 % PGR at 48 weeks vs 73.91% PGRT at 24 weeks, p<0.0001). PGRT tumors demonstrated gene expression programs related to collagen content, EMT and cell movement and was most concordant with human QSB PDAC subtypes and squamoid single cell subtype. Twist1 overexpression cooperated with KrasG12D for PDAC development in vivo and progression towards metastasis and mimicked the human QSB PDAC subtypes. This novel model may offer new perspectives for PDAC research and for the testing of novel therapeutic strategies in an aggressive PDAC subtype.

2026-06-30 | GSE291909 | GEO

Gene expression data from 62 colorectal cancers

Project description:We stratified colorectal tumor samples using a new unsupervised, iterative method based on non-negative matrix factorization (NMF). The resulting five subtypes exhibited activation of specific signaling pathways, and significant differences in microsatellite status and tumor location. We could also align three CRC cell lines panels to these subtypes.

2013-01-14 | GSE35896 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data